Type 2 diabetes (T2D) is the most common type of diabetes, with prevalence increasing worldwide due to the popularization of a Western lifestyle characterized by overnutrition and limited exercise. According

NOW LIVE: We are very excited that our equity crowdfunding campaign is live on Start Engine! The Press Release of this campaign has been widely published in major social media

To support the United States FDA-approved phase 2 clinical trials of Stem Cell Educator therapy and find a cure for type 1 diabetes and other autoimmune diseases, we are excited

We are delighted to announce that Dr. Yong Zhao, founder and CEO at Throne, will give an oral presentation about the Stem Cell Educator therapy in type 1 diabetes at

Type 1 diabetes (T1D) is an autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals worldwide have T1D, and its incidence increases during the pandemic

Throne Biotechnologies (Throne) is developing Stem Cell Educator therapy to treat type 1 diabetes (T1D) and other autoimmune/inflammation-associated diseases. T1D is an autoimmune disease that causes a deficit of islet

Type 1 diabetes (T1D) is an organ-specific disease characterized by the deficiency of insulin caused by the autoimmune destruction of pancreatic islet β cells. Stem cell-based therapies play essential roles

Here at Throne Biotechnologies, we are pleased to announce Dr. Theodore Mazzone, M.D., as our new chief medical officer. Dr. Mazzone has been a clinical physician, scientist, and professor for nearly